Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zhen Huan

Showing results (131-140 of 165) with videos related to

Pageof 17
Sort By:
Journal of Medical Virology|July 10, 2020
Duration of SARS-CoV-2 RNA shedding and factors associated with prolonged viral shedding in patients with COVID-19Tong-Zeng Li, Zhen-Huan Cao, Yu Chen, et al.
Current Oncology (Toronto, Ont.)|February 26, 2026
Real-World Outcomes of Axicabtagene Ciloleucel for Treatment of Relapsed or Refractory Large B-Cell Lymphoma in CanadaChristopher Lemieux, John Kuruvilla, Mona Shafey, et al.
Blood Advances|November 10, 2020
Genetic factors rather than blast reduction determine outcomes of allogeneic HCT in BCR-ABL-negative MPN in blast phaseVikas Gupta, James A Kennedy, Jose-Mario Capo-Chichi, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|March 9, 2021
Construction of a comprehensive nutritional index and comparison of its prognostic performance with the PNI and NRI for survival in older patients with nasopharyngeal carcinoma: a retrospective studyYu-Yu Duan, Jun Deng, Dong-Fang Su, et al.
The New England Journal of Medicine|February 9, 2017
Prognostic Mutations in Myelodysplastic Syndrome after Stem-Cell TransplantationR Coleman Lindsley, Wael Saber, Brenton G Mar, et al.
Blood|July 2, 2014
Tacrolimus/sirolimus vs tacrolimus/methotrexate as GVHD prophylaxis after matched, related donor allogeneic HCTCorey Cutler, Brent Logan, Ryotaro Nakamura, et al.
Blood|December 28, 2020
Short telomere length predicts nonrelapse mortality after stem cell transplantation for myelodysplastic syndromeMikko Myllymäki, Robert Redd, Christopher R Reilly, et al.
Transplantation and Cellular Therapy|January 12, 2026
Impact of Complete Response on Long-Term Survival in Patients With Relapsed or Refractory Large B-cell Lymphoma: A CIBMTR Prospective Study and SLR/Meta-AnalysisArmin Ghobadi, Theodora Anagnostou, Jacques Azzi, et al.
Transplantation and Cellular Therapy|May 24, 2022
Real-World Evidence of Axicabtagene Ciloleucel for the Treatment of Large B Cell Lymphoma in the United StatesCaron A Jacobson, Frederick L Locke, Long Ma, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 15, 2016
Graft-versus-Host Disease after HLA-Matched Sibling Bone Marrow or Peripheral Blood Stem Cell Transplantation: Comparison of North American Caucasian and Japanese PopulationsJunya Kanda, Ruta Brazauskas, Zhen-Huan Hu, et al.
Pageof 17

Showing results (131-140 of 165) with videos related to

Sort By:
Pageof 17
Journal of Medical Virology|July 10, 2020
Duration of SARS-CoV-2 RNA shedding and factors associated with prolonged viral shedding in patients with COVID-19Tong-Zeng Li, Zhen-Huan Cao, Yu Chen, et al.
Current Oncology (Toronto, Ont.)|February 26, 2026
Real-World Outcomes of Axicabtagene Ciloleucel for Treatment of Relapsed or Refractory Large B-Cell Lymphoma in CanadaChristopher Lemieux, John Kuruvilla, Mona Shafey, et al.
Blood Advances|November 10, 2020
Genetic factors rather than blast reduction determine outcomes of allogeneic HCT in BCR-ABL-negative MPN in blast phaseVikas Gupta, James A Kennedy, Jose-Mario Capo-Chichi, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|March 9, 2021
Construction of a comprehensive nutritional index and comparison of its prognostic performance with the PNI and NRI for survival in older patients with nasopharyngeal carcinoma: a retrospective studyYu-Yu Duan, Jun Deng, Dong-Fang Su, et al.
The New England Journal of Medicine|February 9, 2017
Prognostic Mutations in Myelodysplastic Syndrome after Stem-Cell TransplantationR Coleman Lindsley, Wael Saber, Brenton G Mar, et al.
Blood|July 2, 2014
Tacrolimus/sirolimus vs tacrolimus/methotrexate as GVHD prophylaxis after matched, related donor allogeneic HCTCorey Cutler, Brent Logan, Ryotaro Nakamura, et al.
Blood|December 28, 2020
Short telomere length predicts nonrelapse mortality after stem cell transplantation for myelodysplastic syndromeMikko Myllymäki, Robert Redd, Christopher R Reilly, et al.
Transplantation and Cellular Therapy|January 12, 2026
Impact of Complete Response on Long-Term Survival in Patients With Relapsed or Refractory Large B-cell Lymphoma: A CIBMTR Prospective Study and SLR/Meta-AnalysisArmin Ghobadi, Theodora Anagnostou, Jacques Azzi, et al.
Transplantation and Cellular Therapy|May 24, 2022
Real-World Evidence of Axicabtagene Ciloleucel for the Treatment of Large B Cell Lymphoma in the United StatesCaron A Jacobson, Frederick L Locke, Long Ma, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 15, 2016
Graft-versus-Host Disease after HLA-Matched Sibling Bone Marrow or Peripheral Blood Stem Cell Transplantation: Comparison of North American Caucasian and Japanese PopulationsJunya Kanda, Ruta Brazauskas, Zhen-Huan Hu, et al.
Pageof 17